Daiwa Securities Group’s Xeris Biopharma Holdings XERS Stock Holding History

Daiwa Securities Group’s Portfolio XERS Stock Details XERS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-404	Closed	-$3K	–	1454
2025 Q4	$3K	Hold	404	–	–	﹤0.01%	1288
2025 Q3	$3K	Hold	404	–	–	﹤0.01%	1255
2025 Q2	$2K	Hold	404	–	–	﹤0.01%	1235
2025 Q1	$2K	Hold	404	–	–	﹤0.01%	1203
2024 Q4	$1K	Hold	404	–	–	﹤0.01%	1275
2024 Q3	$1K	Hold	404	–	–	﹤0.01%	1263
2024 Q2	$1K	Hold	404	–	–	﹤0.01%	1306
2024 Q1	$1K	Hold	404	–	–	﹤0.01%	1310
2023 Q4	$1K	Hold	404	–	–	﹤0.01%	1313
2023 Q3	$1K	Hold	404	–	–	﹤0.01%	1281
2023 Q2	$1K	Hold	404	–	–	﹤0.01%	1306
2023 Q1	$1K	Hold	404	–	–	﹤0.01%	1286
2022 Q4	$1K	Hold	404	–	–	﹤0.01%	1295
2022 Q3	$1K	Hold	404	–	–	﹤0.01%	1317
2022 Q2	$1K	Hold	404	–	–	﹤0.01%	1328
2022 Q1	$1K	Buy	404 +302	+296%	+$738	﹤0.01%	1348
2021 Q4	$0	Hold	102	–	–	﹤0.01%	1454
2021 Q3	$0	Hold	102	–	–	﹤0.01%	1346
2021 Q2	$0	Hold	102	–	–	﹤0.01%	1293
2021 Q1	$0	Hold	102	–	–	﹤0.01%	1290
2020 Q4	$1K	Sell	102 -68	-40%	-$340	﹤0.01%	1214
2020 Q3	$1K	Hold	170	–	–	﹤0.01%	1170
2020 Q2	$0	Hold	170	–	–	﹤0.01%	1220
2020 Q1	$0	Hold	170	–	–	﹤0.01%	1232
2019 Q4	$1K	Hold	170	–	–	﹤0.01%	1192
2019 Q3	$2K	Hold	170	–	–	﹤0.01%	1137
2019 Q2	$2K	Hold	170	–	–	﹤0.01%	1156
2019 Q1	$2K	Sell	170 -130	-43%	-$1.67K	﹤0.01%	1143
2018 Q4	$5K	Buy	+300	New	+$6.02K	﹤0.01%	1062

Other funds holding XERS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

Rosalind Advisors Toronto, Ontario, Canada $249M AUM 80.12% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Daiwa Securities Group's XERS Position: Q1 2026 in Review

Daiwa Securities Group sold out of Xeris Biopharma Holdings (XERS) in Q1 2026, closing a stake of 404 shares — an estimated $3K sold.

Daiwa Securities Group first reported a position in XERS in Q4 2018 and held it in 29 quarters. The position peaked at $5K in Q4 2018. 237 funds tracked by Wall St. Rank hold XERS as of Q1 2026.

Daiwa Securities Group reported no remaining Xeris Biopharma Holdings position as of Q1 2026 after selling out during the quarter.
Daiwa Securities Group sold 404 Xeris Biopharma Holdings shares in Q1 2026, an estimated $3K.
Daiwa Securities Group first reported a position in Xeris Biopharma Holdings in Q4 2018 and held it in 29 quarters.
Daiwa Securities Group's Xeris Biopharma Holdings position peaked at $5K in Q4 2018.
237 funds tracked by Wall St. Rank held Xeris Biopharma Holdings as of Q1 2026.

Based on Daiwa Securities Group's 13F filing for Q1 2026, filed 13 May 2026.